No Data
No Data
Looking Into Stride's Recent Short Interest
CereVasc Receives Approval for STRIDE Clinical Trial of the EShunt System for the Treatment of Elderly Patients With Normal Pressure Hydrocephalus in Argentina
Fund Update: B. Metzler Seel. Sohn & Co. AG Opened a $2.9M Position in $LRN Stock
Chime Scholars Foundation Applications for 2025-2026 Now Open
LRN Research Unveils Key Gaps and Opportunities in Global Ethics and Compliance Programs
10 Consumer Discretionary Stocks Whale Activity In Today's Session
Unlock the Full List